Dry eye disease (DED) is one of the most common conditions in eyecare, with a significant impact on quality of life because of symptoms including foreign body sensation, pain, blurred vision, dryness or watery eyes. Risk factors include skin pathologies, immunological imbalances, hormonal changes, environmental conditions and poor hygiene.

 

In more than 80% of dry eyes, the cause is a permanent and mostly unnoticed inflammation of the lid margin called blepharitis. In this case, the meibomian glands produce too little and at the same time get plugged with solidified secretions. This leads to an unstable tear film where the eyes are constantly irritated, burning and watering. Treatment is complex and multifactorial, and in some cases undetected bacteria and mites can also be contributors.

​

Intense Pulsed Light (IPL) therapy is the newest and most promising form of therapy for chronic blepharitis (inflammation of the eyelid margin) and meibomian gland dysfunction (MGD). IPL can causally stop the chronic inflammatory processes, can eliminate bacteria and mites, and can restimulate the meibomian glands.